OneCell Diagnostics is now 1Cell.Ai
OneCell Diagnostics is now 1Cell.Ai
OncoDiscover® is a patented, innovative test designed to detect and monitor Circulating Tumor Cells (CTCs) in the bloodstream.
Built on a proprietary multicomponent nanotechnology platform (OncoViu® Kit), it enables real-time tracking of minimal residual disease (MRD) and potential metastatic spread in patients post-treatment—offering earlier relapse detection than traditional imaging.
OncoDiscover® provides oncologists with a sensitive, non-invasive tool to detect minimal residual disease (MRD) and track recurrence earlier than conventional methods like CT or MRI scans.
Detects and monitors disease relapse through CTC analysis
Enables early identification of minimal residual disease (MRD)
Non-invasive blood test requiring only a 5 mL sample
Patented multicomponent CTC capture platform (PCT/IB2016/050779)
Rapid turnaround time (TAT = 7 Days) from sample collection to report
ISO 13485:2016 certified laboratory analysis
The OncoDiscover® platform uses a proprietary nanoparticle-based capture system (OncoViu® Kit) combining iron oxide, glutathione, dendrimers (PAMAM), graphene, and targeting antibodies to selectively isolate CTCs from blood samples.
Captured CTCs are characterized using markers such as CD45, CK18, and DAPI, confirming their identity as tumor-derived cells.
Detection of CTCs enables early monitoring of minimal residual disease, often months before conventional imaging can reveal clinical signs of recurrence.
Monitor MRD in post-treatment cancer patients
Enable earlier therapeutic interventions upon detection of disease relapse
Track metastatic progression in real time
Gain non-invasive post-treatment surveillance
Access earlier detection of relapse, potentially improving outcomes
Patented technology validated under international standards
Licensed by DCG(I) (License No. MFG/IVD/2019/000031)
Recognized with “Innovator of the Year 2019” award by the Department of Biotechnology, Government of India
Backed by ISO 13485:2016 certification
Designed to fit real-world clinical needs with affordable logistics and fast reporting
| Patient Counseling | Patient referred by oncologist for OncoDiscover® CTC Test |
| Sample Collection | 5 mL blood collected into vacutainer tube |
| Sample Transport | Sent under controlled conditions to 1Cell.Ai lab in Pune |
| Sample Analysis | Performed using the OncoViu® Liquid Biopsy Kit |
| Report Delivery | Emailed to the referring oncologist within 7 days |
